InvestorsHub Logo
Followers 0
Posts 75440
Boards Moderated 6
Alias Born 05/24/2005

Re: coolbreeze69 post# 22442

Monday, 12/28/2015 10:55:00 PM

Monday, December 28, 2015 10:55:00 PM

Post# of 113651
NICE NICE......CONCLUSION: Our studies have identified Adva-27a as a novel topoisomerase II inhibitor with superior cytotoxic activity against multidrug-resistant human cancer cells and more desirable pharmacokinetic properties than etoposide.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News